Market revenue in 2023 | USD 68.7 million |
Market revenue in 2030 | USD 201.5 million |
Growth rate | 16.6% (CAGR from 2023 to 2030) |
Largest segment | Web & cloud based |
Fastest growing segment | Web & Cloud based |
Historical data | 2017 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Web & Cloud based, On premise |
Key market players worldwide | IQVIA Holdings Inc, Medidata, Oracle Corp, DATATRAK International Inc, Clario, PAREXEL, Labcorp Holdings Inc, Veeva Systems Inc Class A, Wipro Ltd ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trials management system market will help companies and investors design strategic landscapes.
Web & cloud based was the largest segment with a revenue share of 70.74% in 2023. Horizon Databook has segmented the Japan clinical trials management system market based on web & cloud based, on premise covering the revenue growth of each sub-segment from 2017 to 2030.
Japan has consistently remained the largest market for clinical trials in the region, exhibiting moderate growth during the forecast period. In April 2018, the Clinical Trials Act came into effect in Japan, bringing about significant changes to support clinical research on humans.
Regulations were strengthened and classified under special clinical trials for tests that require marketing authorization for medical devices or pharmaceutical drugs. As a result of the Act, the clinical observational study increased while the clinical interventional study was severely reduced.
The consistent growth of the country’s market can also be attributed to technological innovations, coupled with the rising collaboration of global market players and their expansion of distribution networks. Furthermore, an upward shift in medical expenditure is a key growth factor of the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan clinical trials management system market , including forecasts for subscribers. This country databook contains high-level insights into Japan clinical trials management system market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account